EUVIMEDEUVIMED entdecken
Crossref

Sunitinib promotes apoptosis via p38 MAPK activation and STAT3 downregulation in oral keratinocytes

Shohei Fukada iD, Kouji Ohta iD, Miyuki Sakuma, Misaki Akagi iD, Hiroki Kato, Takako Naruse, Takayuki Nakagawa, Hideo Shigeishi, Hiromi Nishi, Masaaki Takechi, Tomonao Aikawa

Oral Diseases · 2024-03 · 30 (2) · 639-649

DOI: 10.1111/odi.14457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 04.01.2023. Verfasst von Shohei Fukada und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Hiromi Nishi, Kouji Ohta.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Sunitinib, a targeted cancer drug, inhibits tyrosine kinases receptors and is widely used as first‐line treatment for metastatic renal cell carcinoma. Patients undergoing chemotherapy with sunitinib frequently have oral mucosal complications, such as oral stomatitis, though cytotoxic effects of the drug on oral keratinocytes remain unknown.

Methods

The effects of sunitinib on immortalized oral keratinocytes, RT7 cells, in regard to cell injury and apoptosis, as well as apoptosis‐mediated signaling pathways were investigated.

Results

Sunitinib treatment caused a significant increase in lactate dehydrogenase (LDH) in RT7 cells and primary oral keratinocytes. Additionally, the drug induced apoptosis‐related events, such as DNA fragmentation, decreased anti‐apoptotic Bcl‐2 protein expression, and induction of cleaved PARP and caspase 3/9 in RT7 cells. Furthermore, phosphorylation of p38 MAPK, but not of ERK or JNK, was increased. On the contrary, constitutive phosphorylated STAT3 was decreased by sunitinib treatment, which was recovered by exposure to SB203580, a p38 MAPK inhibitor. Finally, SB203580 was found to reduce sunitinib‐induced cell injury and apoptosis.

Conclusion

The present results indicate that sunitinib promotes cell injury and apoptosis in oral keratinocytes via p38 activation and STAT3 downregulation. Sunitinib‐mediated oral complications may be associated with cytotoxic effects of the drug on oral keratinocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsAntineoplastic AgentsHumansSunitinibp38 Mitogen-Activated Protein KinasesDown-RegulationApoptosisKeratinocytesSTAT3 Transcription Factor

Stichwörter der Autor:innen

STAT3apoptosisoral keratinocytesp38 MAPKsunitinib

Substanzen

Sunitinibp38 Mitogen-Activated Protein KinasesAntineoplastic AgentsSTAT3 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Public Oral Health, Program of Oral Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Department of Dentistry, Oral and Maxillofacial Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Kure, Japan.
  • Department of General Dentistry, Hiroshima University Hospital, Hiroshima, Japan.

ORCID-Profile: Shohei Fukada, Kouji Ohta, Misaki Akagi

Förderung

  • Hiromi Nishi
  • Kouji Ohta

Zitieren

APA

Fukada, S., Ohta, K., Sakuma, M., Akagi, M., Kato, H., Naruse, T., Nakagawa, T., Shigeishi, H., Nishi, H., Takechi, M., & Aikawa, T. (2024). Sunitinib promotes apoptosis via p38 MAPK activation and STAT3 downregulation in oral keratinocytes. Oral Diseases, 30(2), 639-649. https://doi.org/10.1111/odi.14457

Vancouver

Fukada S, Ohta K, Sakuma M, Akagi M, Kato H, Naruse T, et al. Sunitinib promotes apoptosis via p38 MAPK activation and STAT3 downregulation in oral keratinocytes. Oral Diseases. 2024;30(2):639-649. doi:10.1111/odi.14457

BibTeX
@article{Fukada2024,
  author = {Fukada, Shohei and Ohta, Kouji and Sakuma, Miyuki and Akagi, Misaki and Kato, Hiroki and Naruse, Takako and Nakagawa, Takayuki and Shigeishi, Hideo and Nishi, Hiromi and Takechi, Masaaki and Aikawa, Tomonao},
  title = {Sunitinib promotes apoptosis via p38 MAPK activation and STAT3 downregulation in oral keratinocytes},
  journal = {Oral Diseases},
  year = {2024},
  volume = {30},
  number = {2},
  pages = {639--649},
  doi = {10.1111/odi.14457}
}
Kostenlos starten →